Get started Log in

6600 — SciClone Pharmaceuticals (Holdings) Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Market Cap
HK$11.81bn
Enterprise Value
HK$9.70bn
Revenue
CNY3.16bn

Brief: SciClone Expects FY Unaudited Profit Attributable Of At Least RMB915 Mln
25/02/2022 24:03
Brief: Sciclone Pharmaceuticals Announces Exclusive License Agreement
16/09/2021 02:23
Brief: Sciclone Pharmaceuticals NMPA Grants Priority Review To BLA Of Danyelza (Naxitamab)
10/09/2021 13:51
HK-listed SciClone Pharma jumps on inclusion in Shenzhen-HK stock connect program
06/09/2021 08:56
Brief: Sciclone Pharmaceuticals Says HY Net Profit About Rmb622.7 Mln, Up 4.3%
20/08/2021 07:34
Brief: Sciclone PharmaSays Nmpa Accepted BLA Of Danyelza (Naxitamab-Gqgk)
13/07/2021 02:36
SciClone Pharma tests hepatitis drug as COVID-19 vaccine enhancer
26/04/2021 08:38
Brief: SciClone Says Study For COVID-19 Inactivated Vaccine With Thymalfasin Initiated
26/04/2021 01:43
Brief: SciClone Pharmaceuticals Announces Formation Of Strategic Cooperation With SF Pharmaceuticals
23/04/2021 02:28
China's biopharmaceutical firm SciClone slips in Hong Kong debut
03/03/2021 01:51